Ownership history in UBS Group AG · 28 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in SCPHARMACEUTICALS INC (SCPH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 117,255 | -738,047 | -86.3% | 0.00% | $665K | — |
| 2025 Q2 | ADDED | 855,302 | +527,887 | +161.2% | 0.00% | $3.3M | — |
| 2025 Q1 | REDUCED | 327,415 | -709,864 | -68.4% | 0.00% | $861K | — |
| 2024 Q4 | ADDED | 1,037,279 | +1,017,775 | +5218.3% | 0.00% | $3.7M | — |
| 2024 Q3 | ADDED | 19,504 | +10,734 | +122.4% | 0.00% | $89K | — |
| 2024 Q2 | REDUCED | 8,770 | -25,464 | -74.4% | 0.00% | $38K | — |
| 2024 Q1 | ADDED | 34,234 | +4,739 | +16.1% | 0.00% | $172K | — |
| 2023 Q4 | ADDED | 29,495 | +14,963 | +103.0% | 0.00% | $185K | — |
| 2023 Q3 | REDUCED | 14,532 | -2,165 | -13.0% | 0.00% | $103K | — |
| 2023 Q2 | ADDED | 16,697 | +13,607 | +440.4% | 0.00% | $170K | — |
As of 2025 Q3 — sorted by position size